<- Go Home

CellMetrix, Inc.

CellMetrix, Inc. operates as medical technology company that develops clinical testing applications and automated laboratory systems that together allow for the early detection, diagnosis, characterization, treatment, and monitoring of significant human diseases. The company currently is focused on developing clinical testing applications for lung cancer and has already fully developed and begun marketing its first clinical application called LungCheck to targeted healthcare providers.

Market Cap

$21.9K

Volume

25.6K

Cash and Equivalents

$9.0K

EBITDA

-$3.8M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$42.0K

Profit Margin

82.35%

52 Week High

$0.00

52 Week Low

$0.00

Dividend

N/A

Price / Book Value

0.03

Price / Earnings

-0.00

Price / Tangible Book Value

-0.01

Enterprise Value

N/A

Enterprise Value / EBITDA

N/A

Operating Income

-$4.0M

Return on Equity

N/A

Return on Assets

N/A

Cash and Short Term Investments

$9.0K

Debt

$1.2M

Equity

$866.0K

Revenue

$51.0K

Unlevered FCF

N/A

Sector

Health Care Equipment and Supplies

Category

N/A

Company Stock Pitches